Fulgent Genetics, Inc. (FLGT)
About Fulgent Genetics, Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $322.7M
- Net income
- -$60.5M
- Total assets
- $1.2B
- Market cap
- $543.9M
- Gross margin
- 40.6%
- Operating margin
- -28.2%
- Net margin
- -19.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $322.7M
- Cost of revenue
- $191.8M
- Gross profit
- $130.9M
- Operating expenses
- $222.0M
- Operating income
- -$91.1M
- Income tax
- -$8.4M
- Net income
- -$61.6M
Balance sheet
- Total assets
- $1.2B
- Current assets
- $550.5M
- Total liabilities
- $106.8M
- Current liabilities
- $85.0M
- Shareholders’ equity
- $1.1B
Cash flow
- Operating cash flow
- -$101.6M
- Investing cash flow
- $111.4M
- Financing cash flow
- -$14.8M
- Net cash flow
- -$5.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $543.9M
- Shares outstanding
- 27.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 29, 2016
Fulgent Genetics, Inc. (FLGT) Stock Price
- Reported a net loss of $60.5M in FY2025.
- Revenue declined 67% from FY2021 to FY2025.
- Gross margin of 40.6%, net margin -19.1%.
- Trading 36% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Fulgent Genetics, Inc..
Write a review
News about Fulgent Genetics, Inc.
News & sentiment via Polygon.io
Fulgent Genetics, Inc.: frequently asked questions
Is Fulgent Genetics, Inc. an American company?
Fulgent Genetics, Inc. is a US-based company headquartered in El Monte, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Fulgent Genetics, Inc. headquartered?
Fulgent Genetics, Inc. is headquartered in El Monte, California, United States.
Is Fulgent Genetics, Inc. publicly traded?
Yes — Fulgent Genetics, Inc. is a publicly traded company. Its stock trades under the ticker symbol FLGT on the NASDAQ.
What does Fulgent Genetics, Inc. do?
Fulgent Genetics, Inc. is an American Medical Devices company in the Health & Beauty sector.
